Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Xeris Biopharma Holdings Inc. buy Craig Hallum

Start price
€4.21
10.03.25 / 50%
Target price
€5.98
10.03.26
Performance (%)
62.15%
Price
€6.82
09.01.26
Summary
This prediction is currently active. With a performance of 62.15% the BUY prediction by Craig_Hallum is a big success. This prediction currently runs until 10.03.26. The prediction end date can be changed by Craig_Hallum at any time. Craig_Hallum has 50% into this prediction
Performance without dividends (%)
Name 1w 1m
Xeris Biopharma Holdings Inc. 8.599% 8.599%
iShares Core DAX® 3.002% 3.742%
iShares Nasdaq 100 2.966% 1.308%
iShares Nikkei 225® 5.606% 4.472%
iShares S&P 500 2.312% 1.880%

Comments by Craig_Hallum for this prediction

In the thread Xeris Biopharma Holdings Inc. diskutieren
Prediction Buy
Perf. (%) 62.15%
Target price 5.982
Change
Ends at 10.03.26

Xeris Biopharma Holdings, Inc. (NASDAQ: XERS) had its price target raised by analysts at Craig Hallum from $5.00 to $6.50. They now have a "buy" rating on the stock.
Ratings data for XERS provided by MarketBeat

Stopped prediction by Craig_Hallum for Xeris Biopharma Holdings Inc.

buy
Xeris Biopharma Holdings Inc.

Start price
Target price
Perf. (%)
€2.12
28.08.23
€4.16
28.08.24
20.38%
29.08.24